Global Bio-chem Technology Group Company Limited
GBCMF
$0.005
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 256.51M | 243.52M | 230.67M | 203.11M | 175.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 256.51M | 243.52M | 230.67M | 203.11M | 175.57M |
| Cost of Revenue | 228.46M | 218.77M | 209.20M | 189.57M | 169.97M |
| Gross Profit | 28.05M | 24.75M | 21.47M | 13.53M | 5.60M |
| SG&A Expenses | 45.41M | 47.59M | 49.78M | 48.53M | 47.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -27.80K | -4.31M | -8.58M | -4.31M | -37.10K |
| Total Operating Expenses | 273.84M | 262.05M | 250.40M | 233.79M | 217.22M |
| Operating Income | -17.33M | -18.53M | -19.73M | -30.69M | -41.66M |
| Income Before Tax | 95.84M | 278.42M | 460.86M | 467.10M | 473.34M |
| Income Tax Expenses | -3.08M | -2.28M | -1.48M | -3.42M | -5.37M |
| Earnings from Continuing Operations | 98.92 | 280.69 | 462.34 | 470.53 | 478.71 |
| Earnings from Discontinued Operations | -- | 34.99M | 69.93M | 65.76M | 61.59M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -1.93M | -3.86M | -1.94M | -9.50K |
| Net Income | 98.92M | 313.75M | 528.41M | 534.36M | 540.30M |
| EBIT | -17.33M | -18.53M | -19.73M | -30.69M | -41.66M |
| EBITDA | 9.91M | 11.63M | 13.36M | 3.93M | -5.51M |
| EPS Basic | 0.01 | 0.04 | 0.06 | 0.06 | 0.06 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.01 | 0.03 | 0.03 | 0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 35.71B | 35.67B | 35.63B | 35.63B | 35.63B |
| Average Diluted Shares Outstanding | 104.79B | 80.55B | 56.32B | 56.32B | 56.32B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |